Levomefolate calcium 1304 views0 applications

Australian approved name (AAN): Levomefolate calcium

Common names and synonyms:
Levomefolate calcium anhydrous
Levomefolinate calcium
Calcium L-5-methyltetrahydrofolate
Folate
Vitamin B9

Molecular formula: C20H23CaN7O6

Molecular weight: 497.52

Conversion (% Levomefolic acid): 92.35

RDI for Vitamin B9 as per NHMRC:
Infants 0-6 months 65µg/day (as folate) (AI)
Infants 7-12 months 80µg/day
Children – 1-3 years – 150µg/day (AI)
Children – 4-8 years – 200µg/day (AI)
Children – 9-13 years – 300µg/day
Children – 14–18 years – 400µg/day
Adults – 400µg/day
Pregnancy – 600µg/day
Lactation – 500µg/day

Mandatory component: Levomefolic acid

Maximum daily dose: The maximum recommended daily dose must not provide more than 500 micrograms of Levomefolic acid from Levomefolate calcium. When the medicine contains a combination of folic acid, folinic acid or levomefolic acid, the medicine must not provide more than a combined total of 500 micrograms of folic acid, folinic acid and levomefolic acid per maximum recommended daily dose.

Warnings and Restrictions: Available for medicines intended for internal use only.

VIT – Vitamins can only be of assistance if the dietary vitamin intake is inadequate. OR Vitamin supplements should not replace a balanced diet.

When used in preparations indicated for reducing the risk of having a child with spina bifida/neural tube defects the following warning statement is required on the medicine label:
NEUR – Warning: Do not exceed the stated dose except on medical advice. If you have had a baby with a neural tube defect/spina bifida – seek specific medical advice (or words to that effect).

Alllowable purpose of the ingredient: Active

TGA reference: Merck Index

Apply for this resource
Share this resource